ts BCR-ABL kinase activation confers increased resistance to genotoxic damage via cell cycle block.
Year: 1996
Type: article
Source: PubMed
Authors: K Nishii, J H Kabarowski, D L Gibbons, S D Griffiths, I Titley, L M Wiedemann, M F Greaves
Institution: Institute of Cancer Research
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2398252182
